IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing

  • Francesca Spadaro
    Department of Cell Biology and Neurosciences, Section of Experimental Immunotherapy, Istituto Superiore di Sanità, Rome, Italy;
  • Caterina Lapenta
    Department of Cell Biology and Neurosciences, Section of Experimental Immunotherapy, Istituto Superiore di Sanità, Rome, Italy;
  • Simona Donati
    Department of Cell Biology and Neurosciences, Section of Experimental Immunotherapy, Istituto Superiore di Sanità, Rome, Italy;
  • Laura Abalsamo
    Department of Cell Biology and Neurosciences, Section of Experimental Immunotherapy, Istituto Superiore di Sanità, Rome, Italy;
  • Vincenzo Barnaba
    Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Rome, Italy; and
  • Filippo Belardelli
    Department of Cell Biology and Neurosciences, Section of Experimental Immunotherapy, Istituto Superiore di Sanità, Rome, Italy;
  • Stefano M. Santini
    Department of Cell Biology and Neurosciences, Section of Experimental Immunotherapy, Istituto Superiore di Sanità, Rome, Italy;
  • Maria Ferrantini
    Department of Cell Biology and Neurosciences, Section of Experimental Immunotherapy, Istituto Superiore di Sanità, Rome, Italy;

抄録

<jats:title>Abstract</jats:title> <jats:p>Cross-presentation allows antigen-presenting cells to present exogenous antigens to CD8+ T cells, playing an essential role in controlling infections and tumor development. IFN-α induces the rapid differentiation of human mono-cytes into dendritic cells, known as IFN-DCs, highly efficient in mediating cross-presentation, as well as the cross-priming of CD8+ T cells. Here, we have investigated the mechanisms underlying the cross-presentation ability of IFN-DCs by studying the intracellular sorting of soluble ovalbumin and nonstructural-3 protein of hepatitis C virus. Our results demonstrate that, independently from the route and mechanism of antigen entry, IFN-DCs are extraordinarily competent in preserving internalized proteins from early degradation and in routing antigens toward the MHC class-I processing pathway, allowing long-lasting, cross-priming capacity. In IFN-DCs, both early and recycling endosomes function as key compartments for the storage of both antigens and MHC-class I molecules and for proteasome- and transporter-associated with Ag processing–dependent auxiliary cross-presentation pathways. Because IFN-DCs closely resemble human DCs naturally occurring in vivo in response to infections and other danger signals, these findings may have important implications for the design of vaccination strategies in neoplastic or chronic infectious diseases.</jats:p>

収録刊行物

  • Blood

    Blood 119 (6), 1407-1417, 2012-02-09

    American Society of Hematology

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ